ABIGAIL CARROLL brings her experience at the U.S. Food and Drug Administration (FDA) and scientific background to advise clients on regulatory and policy issues. She provides strategic advice and counsels companies in the pharmaceutical, biotech, medical device, AI/digital health, and food spaces.
Prior to joining Sidley, Abigail served as regulatory counsel in the FDA’s Office of the Center Director for the Center for Devices and Radiological Health (CDRH). There, she served on the chief of staff team to prioritize Center activities, including supporting statutory and administrative actions in furtherance of diagnostic regulatory reform. In recognition for her work at CDRH, Abigail earned a “Commissioner’s Special Citation.”
Abigail also worked as a detailee to the Energy and Commerce Committee in the U.S. House of Representatives, which provides oversight of FDA. In that role, she provided legal and policy counsel, analysis, and recommendations to the chair, members, and staff on FDA-related issues.
From 2019 to 2022, she was the sole research and editorial assistant to Dr. Scott Gottlieb, former FDA commissioner, covering a wide range of FDA and health policy issues, including public health infrastructure and scientific and policy issues relating to the COVID-19 pandemic.
While attending Georgetown University Law Center’s Evening Program, Abigail served as the executive editor of the Food and Drug Law Journal.